|
Pre- and post-vaccination seroprotection rate (percentage of subjects with haemagglutination inhibition titre ≥ 1:40) |
|||
| Viral strain |
Vaccination status |
Sub/MF59™, % (n = 367) |
Subunit, % (n = 187) |
|
|
|||
| A/H1N1 |
Pre-vaccination |
98.4 |
97.3 |
| Post-vaccination |
99.7 |
99.5 |
|
| A/H3N2 |
Pre-vaccination |
21.5 |
18.7 |
| Post-vaccination |
88.0* |
72.2 |
|
| B |
Pre-vaccination |
2.2 |
2.1 |
| Post-vaccination |
35.7 |
28.3 |
|
|
*P < 0.001 versus the Subunit group Sub/MF59™, MF59™-adjuvanted subunit influenza vaccine; Subunit, non-adjuvanted subunit influenza vaccine | |||
Li et al. Immunity & Ageing 2008 5:2 doi:10.1186/1742-4933-5-2 |
|||